TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Thioredoxin Systems AB
Closing information (x1000 SEK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
125
|
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-1,821
|
-3,067
|
-1,777 |
EBITDA |
-1,821
|
-3,048
|
-1,744 |
Total assets |
14,013
|
8,321
|
10,460 |
Current assets |
9,045
|
4,204
|
8,746 |
Current liabilities |
8,738
|
1,227
|
300 |
Equity capital |
5,275
|
7,094
|
10,160 |
- share capital |
124
|
122
![]() |
122 |
Employees (average) |
3
|
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
37.6%
|
85.3%
|
97.1% |
Turnover per employee | 42 | ||
Profit as a percentage of turnover | -1456.8% | ||
Return on assets (ROA) |
-13.0%
|
-36.9%
|
-17.0% |
Current ratio |
103.5%
|
342.6%
|
2915.3% |
Return on equity (ROE) |
-34.5%
|
-43.2%
|
-17.5% |
Change turnover |
125
|
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
3
|
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.